Stoke Therapeutics (STOK) Tax Rate (2025)
Stoke Therapeutics' quarterly Tax Rate came in at 3.23% in Q3 2025, up 188.09% quarter-over-quarter from 1.12% in Q1 2025.
Stoke Therapeutics has reported Tax Rate for 1 years, with the latest figure at 3.23% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 57.14 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 5.61 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.68 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -6.79 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.51 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7.07 |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.23 |
| Sep 30, 2025 | 3.23 |
| Mar 31, 2025 | 1.12 |
| Mar 31, 2025 | 1.12 |